<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74-molecules-25-05017">
 <label>74.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rallabhandi</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Phillips</surname>
    <given-names>R.L.</given-names>
   </name>
   <name>
    <surname>Boukhvalova</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Pletneva</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Shirey</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Gioannini</surname>
    <given-names>T.L.</given-names>
   </name>
   <name>
    <surname>Weiss</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Chow</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Hawkins</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>S.N.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2</article-title>
  <source>mBio</source>
  <year>2012</year>
  <volume>3</volume>
  <pub-id pub-id-type="doi">10.1128/mBio.00218-12</pub-id>
  <?supplied-pmid 22872782?>
  <pub-id pub-id-type="pmid">22872782</pub-id>
 </element-citation>
</ref>
